Ngā hua rapu - Catherine M. Vanden Boom
- E whakaatu ana i te 1 - 1 hua o te 1
-
1
Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm mā Barry Greenberg, James D. Neaton, Stefan D. Anker, William M. Byra, John G.F. Cleland, Hsiaowei Deng, Min Fu, David A. La Police, Carolyn S.P. Lam, Mandeep R. Mehra, Christopher C. Nessel, Theodore E. Spiro, Dirk J. van Veldhuisen, Catherine M. Vanden Boom, Faı̈ez Zannad
I whakaputaina 2019Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Alternative medicine
Atrial fibrillation
Cardiology
Clinical endpoint
Coronary artery disease
Ejection fraction
Engineering
Heart failure
Internal medicine
Mechanical engineering
Medicine
Myocardial infarction
Pathology
Placebo
Randomized controlled trial
Rivaroxaban
Sinus rhythm
Stroke (engine)
Warfarin